FHIR © HL7.org  |  FHIRsmith 0.18.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packagede.medizininformatikinitiative.kerndatensatz.mtb
Resource TypeRequestGroup
IdRequestGroup-mii-exa-mtb-request-group-adavosertib-carboplatin.json
FHIR VersionR4

Resources that use this resource

No resources found


Resources that this resource uses

No resources found


Narrative

Note: links and images are rebased to the (stated) source


English


Generated Narrative: RequestGroup mii-exa-mtb-request-group-adavosertib-carboplatin

Profile: MII PR MTB Therapieempfehlung Kombinationstherapie version: 2027.0.0-ballot.1

MII EX MTB Empfehlung Priorität: 4

MII EX MTB Empfehlung Evidenzgraduierung: Predictive value of the biomarker or clinical effectiveness of the drug in a molecularly stratified cohort was demonstrated in a retrospective cohort or case–control study in the same tumor type.

MII EX MTB Empfehlung Publikation: http://www.ncbi.nlm.nih.gov/pubmed/37236033

status: Draft

intent: Proposal

code: Chemotherapie + zielgerichtete Substanzen

subject: Kim Musterperson (no stated gender), DoB: 1956-03-14

authoredOn: 2023-03-28

Actions

-Resource
*MedicationRequest: status = draft; intent = option; medication[x] = Carboplatin; authoredOn = 2023-03-28

German


Generated Narrative: RequestGroup mii-exa-mtb-request-group-adavosertib-carboplatin

Profile: MII PR MTB Therapieempfehlung Kombinationstherapie version: 2027.0.0-ballot.1

MII EX MTB Empfehlung Priorität: 4

MII EX MTB Empfehlung Evidenzgraduierung: m1B

MII EX MTB Empfehlung Publikation: http://www.ncbi.nlm.nih.gov/pubmed/37236033

status: Draft

intent: Proposal

code: Chemotherapie + zielgerichtete Substanzen

subject: Kim Musterperson (no stated gender), DoB: 1956-03-14

authoredOn: 2023-03-28

Actions

-Resource
*MedicationRequest: status = draft; intent = option; medication[x] = Carboplatin; authoredOn = 2023-03-28

Source1

{
  "resourceType": "RequestGroup",
  "id": "mii-exa-mtb-request-group-adavosertib-carboplatin",
  "meta": {
    "profile": [
      "https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-therapieempfehlung-kombination|2027.0.0-ballot.1"
    ]
  },
  "text": {
    "status": "extensions",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-ex-mtb-empfehlung-prioritaet",
      "valuePositiveInt": 4
    },
    {
      "url": "https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-ex-mtb-empfehlung-evidenzgraduierung",
      "valueCodeableConcept": {
        "coding": [
          {
            "system": "https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/CodeSystem/mii-cs-mtb-empfehlung-evidenzgrad",
            "code": "m1B"
          }
        ]
      }
    },
    {
      "url": "https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-ex-mtb-empfehlung-publikation",
      "valueIdentifier": {
        "system": "http://www.ncbi.nlm.nih.gov/pubmed",
        "value": "37236033"
      }
    }
  ],
  "status": "draft",
  "intent": "proposal",
  "code": {
    "coding": [
      {
        "system": "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-typ",
        "code": "CZ",
        "display": "Chemotherapie + zielgerichtete Substanzen"
      }
    ]
  },
  "subject": {
    "reference": "Patient/PatientKimMusterperson"
  },
  "authoredOn": "2023-03-28",
  "action": [
    {
      "resource": {
        "reference": "MedicationRequest/mii-exa-mtb-medication-request-carboplatin"
      }
    }
  ]
}